SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001567619-21-002468
Filing Date
2021-02-08
Accepted
2021-02-08 17:14:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 NONE doc1.htm SC 13G/A 64680
  Complete submission text file 0001567619-21-002468.txt   66570
Mailing Address BANK OF AMERICA CORPORATE CENTER 100 N TRYON ST CHARLOTTE NC 28255
Business Address BANK OF AMERICA CORPORATE CENTER 100 N TRYON ST CHARLOTTE NC 28255 7043868486
BANK OF AMERICA CORP /DE/ (Filed by) CIK: 0000070858 (see all company filings)

IRS No.: 560906609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks

Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Subject) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88976 | Film No.: 21602443
SIC: 2834 Pharmaceutical Preparations